Article
Guideline for blood grouping and red cell antibody testing in pregnancy
13 Apr 2016
Abstract excerpt
The purpose of the guideline is to make evidence-based recommendations for the application of blood grouping and red cell antibody testing in pregnancy. The aim is to predict the potential for, and where possible, prevent, haemolytic disease of the fetus and newborn (HDFN). The blood group and antibody status of a pregnant woman should be tested at booking and at 28 weeks gestation to identify the ABO group and D...
